UNSPSC 85816214: Introduction of other therapeutic substance into peripheral vein, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other therapeutic substance into peripheral vein, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E030GC

UNSPSC 85816214 Introduction of other therapeutic substance into peripheral vein, open approach is a Commodity code that does not align with actual recent state and local procurement activity. The code nominally describes an invasive medical procedure, yet the recent opportunities posted under it center on telehealth platforms, occupational health programs, nursing home operations, cancer screening, emergency medical services, behavioral health, and wellness administration—none of which involve parenteral therapeutic injection. The code shows a substantial mismatch between its technical descriptor and what state and local governments are actually buying.

Recent activity spans California, Georgia, Nevada, Colorado, Kansas, and Florida, with issuing bodies including health plans, county health authorities, counties, municipalities, school districts, and specialized behavioral health departments. Representative solicitations include Inland Empire Health Plan's October 2026 RFI for 24/7 virtual urgent care services; DeKalb County's RFP for medical services (due November 2026); the Nevada Health Authority's RFP for Program of All Inclusive Care for the Elderly (due December 2026, with capitation-based pricing ranging from $4,532 to $8,804 per member monthly); San Mateo Medical Center's RFP for cancer registry services and handheld retinal screening devices (due November 2026); and Colorado's RFP for Enhanced Protective Placement nursing home beds for individuals with neuro-behavioral presentations (due September 2026). A significant body of recent work involves opioid settlement-funded services in Kansas and elsewhere, including treatment expansion, overdose prevention, and stigma reduction initiatives due September 2026. The code's nominal scope does not support these activities, and vendors pursuing state and local work should verify correct code assignment before bid strategy development.